NasdaqCM - Delayed Quote USD

Regencell Bioscience Holdings Limited (RGC)

5.70 -0.67 (-10.52%)
At close: April 23 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Operating Expense
6,273.67
6,273.67
7,617.77
1,381.36
812.37
Operating Income
-6,273.67
-6,273.67
-7,617.77
-1,381.36
-812.37
Other Income Expense
211.34
211.34
23.22
34.62
--
Pretax Income
-6,062.33
-6,062.33
-7,594.56
-1,346.75
-812.37
Net Income Common Stockholders
-5,871.13
-5,871.13
-7,445.94
-1,346.75
-812.37
Diluted NI Available to Com Stockholders
-5,871.13
-5,871.13
-7,445.94
-1,346.75
-812.37
Basic EPS
-0.45
-0.45
-0.58
-0.11
-0.06
Diluted EPS
-0.45
-0.45
-0.58
-0.11
-0.06
Basic Average Shares
13,012.87
13,012.87
12,805.71
12,642.11
12,642.11
Diluted Average Shares
13,012.87
13,012.87
12,805.71
12,642.11
12,642.11
Total Operating Income as Reported
-6,273.67
-6,273.67
-7,617.77
-1,381.36
-812.37
Total Expenses
6,273.67
6,273.67
7,617.77
1,381.36
812.37
Net Income from Continuing & Discontinued Operation
-5,871.13
-5,871.13
-7,445.94
-1,346.75
-812.37
Normalized Income
-5,871.13
-5,871.13
-7,445.94
-1,346.75
-812.37
EBIT
-6,273.67
-6,273.67
-7,617.77
-1,381.36
-812.37
EBITDA
-5,503.98
-5,503.98
-7,013.37
-1,354.91
-802.86
Reconciled Depreciation
769.69
769.69
604.40
26.46
9.52
Net Income from Continuing Operation Net Minority Interest
-5,871.13
-5,871.13
-7,445.94
-1,346.75
-812.37
Normalized EBITDA
-5,503.98
-5,503.98
-7,013.37
-1,354.91
-802.86
6/30/2020 - 7/16/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

QLI Qilian International Holding Group Limited
0.7351
+2.78%
 
UPC Universe Pharmaceuticals INC
2.2000
+12.82%
 
YCBD cbdMD, Inc.
0.9101
-6.66%
 
SXTC China SXT Pharmaceuticals, Inc.
1.0700
+0.94%
 
AKAN Akanda Corp.
0.0919
+0.66%
 
CPHI China Pharma Holdings, Inc.
0.3174
-0.02%
 
ALVO Alvotech
13.40
+0.53%
 
HUGE FSD Pharma Inc.
0.4641
-5.09%
 
PRFX PainReform Ltd.
0.8898
+1.24%
 
SBFM Sunshine Biopharma, Inc.
1.2100
-15.97%